Platform

Best TradingView Alternative in 2026 –
An Honest Comparison

March 29, 2026 · 8 min read · CompoundPulse Team

TradingView is still one of the best charting platforms available. The issue isn't the product — it's that many traders end up paying for charting and then adding separate tools for screening, backtesting, or research workflows that TradingView doesn't cover out of the box.

If you rely on Pine Script or TradingView's social layer, staying there makes sense. If you want charting, screening, and backtesting that works without learning a scripting language — CompoundPulse is built for that workflow.

Bottom line up front: This is not a "TradingView is bad" article. It's a workflow comparison. TradingView can do most of these jobs. The question is whether the extra friction — Pine Script for backtesting, additional data subscriptions for real-time feeds, separate tools for some research workflows — is worth the cost for the way you actually trade.

What TradingView Charges You For

Here's the TradingView pricing breakdown as of 2026. Note that some exchanges charge additional real-time data fees on top of the subscription price — so your actual cost may be higher depending on what markets you trade.

PlanPriceKey Notes
Free$02 indicators per chart, 3 active price alerts, data timing varies by feed
Essential$12.95/mo (billed annually)5 indicators, 20 price alerts, 30-day trial
Plus$29.95/mo (billed annually)10 indicators, 100 price alerts, 30-day trial
Premium$59.95/mo (billed annually)25 indicators per chart, 400 price alerts, 30-day trial — exchange data add-ons may apply separately

Feature-for-Feature: TradingView Plus vs CompoundPulse Pro

FeatureTradingView Plus ($29.95)CompoundPulse Pro
Technical indicators10 per chart75+ per chart, all enabled
Chart typesCandle, Bar, Line, Area, HASame 5 types
Timeframes1m → Monthly1m → 5Y
Drawing toolsFull suiteFull suite + saved to cloud
Symbol comparison overlayYesYes — type "vs…" on any chart
Chart replay (bar-by-bar)Yes (Pro+ only)Yes — all plans
Multi-chart layoutUp to 4 panesUp to 4 panes, each with own ticker
Stock screenerMany filters; separate from main chart workflowFinviz-style, many filters, opens directly in chart
BacktestingStrategy Tester — strongest with Pine ScriptBuilt-in, zero code required
Options chain dataBasicFull options page
Insider activityAvailable via News Flow / corporate toolsDedicated tracker — every Form 4 filing
Earnings calendarYesYes
Economic calendarYesYes
Market heatmapsYesYes
Crypto / Forex / FuturesYesYes — dedicated pages per asset class
Asset correlationAvailable via official indicatorBuilt-in matrix — stocks, ETFs, crypto, forex
Price alerts20 alertsUnlimited — email + browser push
Paper tradingYes (Premium only)Yes
Portfolio trackerBasicYes
Free trial30-day trial on paid plans7-day trial, no credit card required
Market data feesSome exchanges require add-on subscriptionsCheck pricing page for current data terms

Where the Workflow Difference Actually Shows Up

TradingView can do most of these jobs. What the table above doesn't fully capture is how much friction sits between you and the result in each case. Here's where that gap is most noticeable in practice:

1. Backtesting Pushes You Toward Pine Script

TradingView's Strategy Tester is genuinely capable — you can backtest built-in strategies and community scripts without writing a line of code. But the moment you want to test your own rules with custom logic, you're writing Pine Script. For most retail traders, that's where the workflow stops. The learning curve is real, and the time cost is real.

CompoundPulse's backtester is built for traders who don't want to write code at all. Pick a ticker, pick a strategy, hit run. You get a full equity curve, win rate, max drawdown, Sharpe ratio, and comparison to buy-and-hold — in about 10 seconds.

2. Insider Activity Lives in a Different Part of the Platform

TradingView surfaces some corporate activity through its News Flow, but it's not a dedicated insider trading tracker. Finding Form 4 filings — who bought, who sold, how many shares, at what price — requires leaving the chart and hunting for the data elsewhere.

CompoundPulse keeps a dedicated insider tracker alongside every chart. When the CFO of a company you're watching quietly buys $1.5M of their own stock, that shows up in your research workflow without a separate tab.

3. The Screener Lives in a Separate Workflow

TradingView's screener is capable — a wide range of filter fields across multiple screener types. But it lives separately from the charting environment. You screen for a setup, then manually open the chart in another view. For traders who move between screener and chart dozens of times a session, that friction compounds.

On CompoundPulse, a screener result opens directly into the chart with your indicator layout already applied. No tab switching, no re-applying settings.

4. Correlation Requires a Separate Indicator Setup

TradingView has a correlation heatmap available as an official indicator. It works, but it requires adding it to a chart and configuring it manually each time. CompoundPulse has a standalone correlation matrix page — add any mix of tickers and see the full correlation grid immediately, without indicator setup.

Where TradingView Still Wins

Being honest matters. Here's where TradingView is genuinely better:

Our honest take: If you're a heavy Pine Script user with hundreds of saved scripts, switching costs are real. For everyone else — if you're paying $30/month for charts and a mediocre screener — you should at least try the free trial and compare side by side.

Who Should Switch

Who Should Stay on TradingView

Most traders don't lose because they're bad at this.

They lose because they keep entering without seeing the full picture — the trend, the pressure, the confirmation — and by the time they feel it, they're already trapped. The traders who actually compound aren't smarter. They just see it first. That's what CompoundPulse is built for.

Try CompoundPulse Free — No Credit Card

Related: Best Free Stock Screener · Top 10 Technical Indicators · How to Backtest a Strategy